Suppr超能文献

衡量和评估生产力成本所面临的挑战及其在情绪障碍中的相关性。

Challenges in measuring and valuing productivity costs, and their relevance in mood disorders.

作者信息

Lensberg Benedikte R, Drummond Michael F, Danchenko Natalya, Despiégel Nicolas, François Clément

机构信息

Optuminsight, Uxbridge, UK.

出版信息

Clinicoecon Outcomes Res. 2013 Nov 18;5:565-73. doi: 10.2147/CEOR.S44866. eCollection 2013.

Abstract

Lost productivity is often excluded from economic evaluations, which may lead to an underestimation of the societal benefits of treatment. However, there are multiple challenges in reliably estimating and reporting productivity losses. This article explores the main challenges, ie, selecting an appropriate valuation method (ie, human capital, friction cost, or multiplier), avoiding double counting, and accounting for equity. It also discusses the use of presenteeism instruments and their application in clinical trials, with a specific focus on their relevance in individuals with mood disorders. Further research and discussion is required on the development of reliable techniques for measuring and valuing productivity changes due to presenteeism.

摘要

生产力损失通常被排除在经济评估之外,这可能导致对治疗的社会效益估计不足。然而,在可靠地估计和报告生产力损失方面存在多重挑战。本文探讨了主要挑战,即选择合适的估值方法(即人力资本法、摩擦成本法或乘数法)、避免重复计算以及考虑公平性。本文还讨论了出勤主义衡量工具及其在临床试验中的应用,特别关注其在情绪障碍患者中的相关性。关于开发可靠技术以测量和评估因出勤主义导致的生产力变化,还需要进一步的研究和讨论。

相似文献

1
Challenges in measuring and valuing productivity costs, and their relevance in mood disorders.
Clinicoecon Outcomes Res. 2013 Nov 18;5:565-73. doi: 10.2147/CEOR.S44866. eCollection 2013.
2
The iMTA Productivity Cost Questionnaire: A Standardized Instrument for Measuring and Valuing Health-Related Productivity Losses.
Value Health. 2015 Sep;18(6):753-8. doi: 10.1016/j.jval.2015.05.009. Epub 2015 Aug 20.
3
Production Losses due to Absenteeism and Presenteeism: The Influence of Compensation Mechanisms and Multiplier Effects.
Pharmacoeconomics. 2023 Sep;41(9):1103-1115. doi: 10.1007/s40273-023-01253-y. Epub 2023 Mar 1.
4
Productivity costs in economic evaluations: past, present, future.
Pharmacoeconomics. 2013 Jul;31(7):537-49. doi: 10.1007/s40273-013-0056-3.
7
The Estimation and Inclusion of Presenteeism Costs in Applied Economic Evaluation: A Systematic Review.
Value Health. 2017 Mar;20(3):496-506. doi: 10.1016/j.jval.2016.12.006. Epub 2017 Jan 30.
8
Measuring and valuing productivity loss due to poor health: A critical review.
Soc Sci Med. 2011 Jan;72(2):185-92. doi: 10.1016/j.socscimed.2010.10.026. Epub 2010 Nov 18.
9
A Systematic Review of Productivity in Economic Evaluations of Workplace Interventions: A Need for Reporting Criteria?
Appl Health Econ Health Policy. 2019 Oct;17(5):591-613. doi: 10.1007/s40258-019-00473-8.
10
How to estimate productivity costs in economic evaluations.
Pharmacoeconomics. 2014 Apr;32(4):335-44. doi: 10.1007/s40273-014-0132-3.

引用本文的文献

1
Burden of Chikungunya Fever and Its Economic and Social Impacts Worldwide: A Systematic Review.
Trop Med Int Health. 2025 Sep;30(9):865-892. doi: 10.1111/tmi.70012. Epub 2025 Jul 22.
3
Different attitudes towards estimating indirect costs of disease: The example of cancer.
J Public Health Res. 2025 Apr 17;14(2):22799036251326636. doi: 10.1177/22799036251326636. eCollection 2025 Apr.
4
The need for a broad perspective when assessing value-for-money for out-of-hours primary care.
Prim Health Care Res Dev. 2024 Sep 20;25:e37. doi: 10.1017/S1463423624000318.
5
Estimates of the Lifetime Productivity Costs of Chlamydia, Gonorrhea, and Syphilis in the United States.
Sex Transm Dis. 2024 Oct 1;51(10):635-640. doi: 10.1097/OLQ.0000000000001973. Epub 2024 Apr 19.
7
Future burden of myocardial infarction in Australia: impact on health outcomes between 2019 and 2038.
Eur Heart J Qual Care Clin Outcomes. 2024 Aug 8;10(5):421-430. doi: 10.1093/ehjqcco/qcad062.
9
Multiplier Effects and Compensation Mechanisms for Inclusion in Health Economic Evaluation: A Systematic Review.
Pharmacoeconomics. 2023 Sep;41(9):1031-1050. doi: 10.1007/s40273-023-01304-4. Epub 2023 Aug 17.
10
Production losses from morbidity and mortality by disease, age and sex in Norway.
Scand J Public Health. 2024 Aug;52(6):779-783. doi: 10.1177/14034948231188237. Epub 2023 Jul 28.

本文引用的文献

1
The use and performance of productivity scales to evaluate presenteeism in mood disorders.
Value Health. 2012 Dec;15(8):1148-61. doi: 10.1016/j.jval.2012.08.2206.
3
Presenteeism: critical issues.
J Occup Environ Med. 2010 Nov;52(11):1055-67. doi: 10.1097/JOM.0b013e3181f475cc.
4
Cost of low back pain in Switzerland in 2005.
Eur J Health Econ. 2011 Oct;12(5):455-67. doi: 10.1007/s10198-010-0258-y. Epub 2010 Jun 5.
5
Cost-of-illness of rheumatoid arthritis and ankylosing spondylitis.
Clin Exp Rheumatol. 2009 Jul-Aug;27(4 Suppl 55):S118-23.
6
The cost and impact of health conditions on presenteeism to employers: a review of the literature.
Pharmacoeconomics. 2009;27(5):365-78. doi: 10.2165/00019053-200927050-00002.
7
Difficulties in calculating productivity costs: work disability associated with borderline personality disorder.
Value Health. 2008 Jul-Aug;11(4):637-44. doi: 10.1111/j.1524-4733.2007.00288.x. Epub 2007 Dec 17.
8
10
Resource use and costs associated with patients treated for depression in primary care.
Eur J Health Econ. 2007 Mar;8(1):67-76. doi: 10.1007/s10198-006-0008-3.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验